163 related articles for article (PubMed ID: 26840258)
1. The effect of HMGB1 on the clinicopathological and prognostic features of non-small cell lung cancer.
Feng A; Tu Z; Yin B
Oncotarget; 2016 Apr; 7(15):20507-19. PubMed ID: 26840258
[TBL] [Abstract][Full Text] [Related]
2. Signaling protein signature predicts clinical outcome of non-small-cell lung cancer.
Jin BF; Yang F; Ying XM; Gong L; Hu SF; Zhao Q; Liao YD; Chen KZ; Li T; Tai YH; Cao Y; Li X; Huang Y; Zhan XY; Qin XH; Wu J; Chen S; Guo SS; Zhang YC; Chen J; Shen DH; Sun KK; Chen L; Li WH; Li AL; Wang N; Xia Q; Wang J; Zhou T
BMC Cancer; 2018 Mar; 18(1):259. PubMed ID: 29510676
[TBL] [Abstract][Full Text] [Related]
3. Comparative Network Analysis of Patients with Non-Small Cell Lung Cancer and Smokers for Representing Potential Therapeutic Targets.
Pazhouhandeh M; Samiee F; Boniadi T; Khedmat AF; Vahedi E; Mirdamadi M; Sigari N; Siadat SD; Vaziri F; Fateh A; Ajorloo F; Tafsiri E; Ghanei M; Mahboudi F; Rahimi Jamnani F
Sci Rep; 2017 Oct; 7(1):13812. PubMed ID: 29062084
[TBL] [Abstract][Full Text] [Related]
4. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Min SH; Zheng QQ
Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
[TBL] [Abstract][Full Text] [Related]
6. High Mobility Group Box Protein 1 Serves as a Potential Prognostic Marker of Lung Cancer and Promotes Its Invasion and Metastasis by Matrix Metalloproteinase-2 in a Nuclear Factor-
Wu X; Wang W; Chen Y; Liu X; Wang J; Qin X; Yuan D; Yu T; Chen G; Mi Y; Mou J; Cui J; Hu A; E Y; Pei D
Biomed Res Int; 2018; 2018():3453706. PubMed ID: 29850505
[TBL] [Abstract][Full Text] [Related]
7. Cuproptosis-related gene
Deng R; Zhu L; Jiang J; Chen J; Li H
Biomol Biomed; 2024 May; 24(3):647-658. PubMed ID: 38041690
[TBL] [Abstract][Full Text] [Related]
8. Insulin Receptor Substrate-1 (IRS-1) and IRS-2 expression levels are associated with prognosis in non-small cell lung cancer (NSCLC).
Piper AJ; Clark JL; Mercado-Matos J; Matthew-Onabanjo AN; Hsieh CC; Akalin A; Shaw LM
PLoS One; 2019; 14(8):e0220567. PubMed ID: 31393907
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone receptor α1 acts as a new squamous cell lung cancer diagnostic marker and poor prognosis predictor.
Mohamed FEZA; Abdelaziz AO; Kasem AH; Ellethy T; Gayyed MF
Sci Rep; 2021 Apr; 11(1):7944. PubMed ID: 33846395
[TBL] [Abstract][Full Text] [Related]
10. Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis.
Yi M; Li T; Qin S; Yu S; Chu Q; Li A; Wu K
Biomed Res Int; 2020; 2020():4169691. PubMed ID: 32149105
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis.
Wang Q; Xu L; Wang G; Chen L; Li C; Jiang X; Gao H; Yang B; Tian W
PLoS One; 2020; 15(11):e0241241. PubMed ID: 33186371
[TBL] [Abstract][Full Text] [Related]
12. High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma.
Wang L; Wang X; Sun N; Liu W
Int Immunopharmacol; 2024 May; 133():112039. PubMed ID: 38613884
[TBL] [Abstract][Full Text] [Related]
13. An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression.
Sheng KL; Kang L; Pridham KJ; Dunkenberger LE; Sheng Z; Varghese RT
Sci Rep; 2020 Dec; 10(1):21246. PubMed ID: 33277589
[TBL] [Abstract][Full Text] [Related]
14. Roles of Lipid Profiles in Human Non-Small Cell Lung Cancer.
Jianyong Z; Yanruo H; Xiaoju T; Yiping W; Fengming L
Technol Cancer Res Treat; 2021; 20():15330338211041472. PubMed ID: 34569862
[No Abstract] [Full Text] [Related]
15. Identification of prognostic markers of lung cancer through bioinformatics analysis and in vitro experiments.
Ling B; Liao X; Huang Y; Liang L; Jiang Y; Pang Y; Qi G
Int J Oncol; 2020 Jan; 56(1):193-205. PubMed ID: 31789390
[TBL] [Abstract][Full Text] [Related]
16. Recombined humanized endostatin-induced suppression of HMGB1 expression inhibits proliferation of NSCLC cancer cells.
Meng FJ; Wang S; Yan YJ; Wang CY; Guan ZY; Zhang J
Thorac Cancer; 2019 Jan; 10(1):90-95. PubMed ID: 30485686
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer.
Hu Q; Wang R; Zhang J; Xue Q; Ding B
Cancer Immunol Immunother; 2023 Dec; 72(12):4293-4308. PubMed ID: 37907644
[TBL] [Abstract][Full Text] [Related]
18. SERPINE1 and SERPINB7 as potential biomarkers for intravenous vitamin C treatment in non-small-cell lung cancer.
Ou J; Liao Q; Du Y; Xi W; Meng Q; Li K; Cai Q; Pang CLK
Free Radic Biol Med; 2023 Nov; 209(Pt 1):96-107. PubMed ID: 37838303
[TBL] [Abstract][Full Text] [Related]
19. The Role of Upregulated
Li J; Liu L; Liu X; Xu P; Hu Q; Yu Y
J Cancer; 2019; 10(18):4208-4216. PubMed ID: 31413739
[No Abstract] [Full Text] [Related]
20. Identifying candidate diagnostic markers for early stage of non-small cell lung cancer.
Wu Z; Zhang X; He Z; Hou L
PLoS One; 2019; 14(11):e0225080. PubMed ID: 31726467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
